Reports and Briefs on Pharmaceuticals

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

5EU: Pricing, Reimbursement and Regulatory Update

Datamonitor’s report 5EU: Pricing, Reimbursement, and Regulatory Update provides an overview of developments regarding healthcare reforms, drug regulation, and drug pricing and reimbursement in France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
28 Oct 2011 $1520
Buy
Report
Report

Abbott Laboratories: Company Analysis

Analysis of Abbott's corporate strategy, marketed portfolio, pipeline potential and financial position in 2011 and to 2017

Published By Datamonitor
08 Aug 2012 $2800
Buy
Report
Report

Acorda Therapeutics: PharmaVitae Report

Analysis of Acorda Therapeutics' corporate history, corporate relationships, prospects to the end of the forecast period, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.

Published By Datamonitor
11 May 2012 $2800
Buy
Report
Report

Actelion Ltd: PharmaVitae Report

Analysis of Actelion's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Oct 2011 $2800
Buy
Report
Report

Affymax, Inc.: PharmaVitae Report

Analysis of Affymax's corporate history, corporate relationships, prospects to the end of the forecast period, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.

Published By Datamonitor
19 Jun 2012 $2800
Buy
Report
Report

Alcon Inc.: PharmaVitae Profile

Analysis of Alcon's corporate strategy, marketed portfolio, pipeline potential and financial position in 2009 and to 2015

Published By Datamonitor
16 Dec 2010 $2800
Buy
Report
Report

Alexion Pharmaceuticals: PharmaVitae Report

This report analyzes Alexion's corporate strategy, sales outlook and financial position through to 2016, supported by in-depth analysis of the company’s key products, driven by patient-based forecasts and key opinion leader interviews.

Published By Datamonitor
14 Sep 2011 $2800
Buy
Report
Report

Allergan Inc.: PharmaVitae Report

Analysis of Allergan's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

Amarin Corporation plc: PharmaVitae Report

Analysis of Amarin's corporate history, corporate relationships, prospects to the end of the forecast period, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.

Published By Datamonitor
27 Jun 2012 $2800
Buy
Report
Report

Amgen Inc.: PharmaVitae Report

Analysis of Amgen's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Jun 2011 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.